Ainos, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
AIMD Nasdaq 3840 www.ainos.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ainos, Inc.

Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization - Jun 30th, 2025 6:00 am
New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V. - Jun 27th, 2025 10:35 am
Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites - Jun 27th, 2025 6:00 am
Ainos Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Stock Consolidation - Jun 26th, 2025 9:00 am
Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia - Jun 24th, 2025 6:00 am
Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25 - Jun 17th, 2025 9:35 am
Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy - Jun 16th, 2025 6:00 am
Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter - Jun 3rd, 2025 6:00 am
Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80% - May 29th, 2025 6:00 am
Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner - May 22nd, 2025 6:00 am
AINOS (NASDAQ: AIMD) Signs Long-Form Interview and National TV Commercial Agreement with New to The Street - May 21st, 2025 12:20 pm
Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy - May 19th, 2025 6:00 am
Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors - May 14th, 2025 6:00 am
Ainos Reports First Quarter 2025 Financial Results - May 12th, 2025 6:00 am
Atossa Therapeutics and Ainos Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - May 5th, 2025 7:00 am
Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing - Apr 30th, 2025 6:12 am
Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly - Apr 23rd, 2025 6:00 am
Ainos and ugo Complete First Robotic Smell Integration in Japan - Apr 21st, 2025 6:00 am
Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan - Apr 14th, 2025 6:00 am
Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor Manufacturing - Smell ID Is Scaling - Apr 11th, 2025 6:00 am